background emerge zoonot paramyxoviru ninth virus niv caps sever respiratory neurology disease human high fatal rate transmit via persontoperson contact pose risk spider outbreak howe broadly applied approach human field set lack method engine new antivirus lipopeptid analyze vitro fusion inhibit identify optic candid prophylaxi infect lower tract ass office differ anim model result show lethal prevent deli rout hamster inhuman prima target recent peptide avoid system delivery individual need prevent thu increase safety treatment enhance until intervene concur expert provide proof concept use antique advance goal ration develop potent lipopeptid inhibitor desire pharmacokinet biodistribut property safe effect method target pathogen virus 